胃癌分子靶向治疗的研究进展

被引:10
作者
张艳
王子安
机构
[1] 安徽省蚌埠医学院第一附属医院肿瘤内科
关键词
胃癌; 靶向治疗; 分子靶向药物;
D O I
10.16766/j.cnki.issn.1674-4152.2015.10.060
中图分类号
R735.2 [胃肿瘤];
学科分类号
100112 [医学生物化学与分子生物学];
摘要
<正>胃癌是世界范围内最常见的恶性肿瘤之一,是第三个最常见的癌症和癌症致死的第二大原因[1]。即便外科手术是治疗胃癌患者的首选方法,但由于早期胃癌临床症状不显著,警戒指标隐匿,导致绝大多数患者在确诊时已出现局部侵犯或远处转移,丧失了手术机会。化疗成为治疗晚期胃癌的最主要手段之一,尽管用于胃癌治疗的化疗药物很多,包括氟尿嘧啶、铂类、紫衫类等,但其联合化疗方案却没有显著提高化疗有效率,胃癌的平均生存期大约在8~11个月。相反的,
引用
收藏
页码:1693 / 1695
页数:3
相关论文
共 9 条
[1]
Potential role of rilotumumab in the treatment of gastric cancer [J].
Waddell, Tom ;
Moorcraft, Sing Yu ;
Cunningham, David .
IMMUNOTHERAPY, 2014, 6 (12) :1243-1253
[2]
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial [J].
Fuchs, Charles S. ;
Tomasek, Jiri ;
Yong, Cho Jae ;
Dumitru, Filip ;
Passalacqua, Rodolfo ;
Goswami, Chanchal ;
Safran, Howard ;
dos Santos, Lucas Vieira ;
Aprile, Giuseppe ;
Ferry, David R. ;
Melichar, Bohuslav ;
Tehfe, Mustapha ;
Topuzov, Eldar ;
Zalcberg, John Raymond ;
Chau, Ian ;
Campbell, William ;
Sivanandan, Choondal ;
Pikiel, Joanna ;
Koshiji, Minori ;
Hsu, Yanzhi ;
Liepa, Astra M. ;
Gao, Ling ;
Schwartz, Jonathan D. ;
Tabernero, Josep .
LANCET, 2014, 383 (9911) :31-39
[3]
2014 Gastrointestinal Cancers Symposium [J].
McLarnon, Andy .
LANCET ONCOLOGY, 2014, 15 (03) :262-262
[4]
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: it is not about the destination, it is about the journey [J].
Scartozzi, Mario ;
Giampieri, Riccardo ;
Del Prete, Michela ;
Faloppi, Luca ;
Bianconi, Maristella ;
Vincenzi, Bruno ;
Tonini, Giuseppe ;
Santini, Daniele ;
Cascinu, Stefano .
EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (01) :143-150
[5]
Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A gemcad study [J].
Martin-Richard, M. ;
Gallego, R. ;
Pericay, C. ;
Foncillas, J. Garcia ;
Queralt, B. ;
Casado, E. ;
Barriuso, J. ;
Iranzo, V. ;
Juez, I. ;
Visa, L. ;
Saigi, E. ;
Barnadas, A. ;
Garcia-Albeniz, X. ;
Maurel, J. .
INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) :1573-1579
[6]
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial [J].
Waddell, Tom ;
Chau, Ian ;
Cunningham, David ;
Gonzalez, David ;
Frances, Alicia ;
Okines, Clare ;
Wotherspoon, Andrew ;
Saffery, Claire ;
Middleton, Gary ;
Wadsley, Jonathan ;
Ferry, David ;
Mansoor, Wasat ;
Crosby, Tom ;
Coxon, Fareeda ;
Smith, David ;
Waters, Justin ;
Iveson, Timothy ;
Falk, Stephen ;
Slater, Sarah ;
Peckitt, Clare ;
Barbachano, Yolanda .
LANCET ONCOLOGY, 2013, 14 (06) :481-489
[7]
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial [J].
Lordick, Florian ;
Kang, Yoon-Koo ;
Chung, Hyun-Cheol ;
Salman, Pamela ;
Oh, Sang Cheul ;
Bodoky, Gyoergy ;
Kurteva, Galina ;
Volovat, Constantin ;
Moiseyenko, Vladimir M. ;
Gorbunova, Vera ;
Park, Joon Oh ;
Sawaki, Akira ;
Celik, Ilhan ;
Goette, Heiko ;
Melezinkova, Helena ;
Moehler, Markus .
LANCET ONCOLOGY, 2013, 14 (06) :490-499
[8]
A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction [J].
Adelstein, David J. ;
Rodriguez, Cristina P. ;
Rybicki, Lisa A. ;
Ives, Denise I. ;
Rice, Thomas W. .
INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) :1684-1689
[9]
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial [J].
Bang, Yung-Jue ;
Van Cutsem, Eric ;
Feyereislova, Andrea ;
Chung, Hyun C. ;
Shen, Lin ;
Sawaki, Akira ;
Lordick, Florian ;
Ohtsu, Atsushi ;
Omuro, Yasushi ;
Satoh, Taroh ;
Aprile, Giuseppe ;
Kulikov, Evgeny ;
Hill, Julie ;
Lehle, Michaela ;
Ruschoff, Josef ;
Kang, Yoon-Koo .
LANCET, 2010, 376 (9742) :687-697